UroGen Pharma Ltd. (URGN)
18.59
+0.11
(+0.60%)
USD |
NASDAQ |
Mar 19, 16:00
18.79
+0.20
(+1.08%)
After-Hours: 04:24
UroGen Pharma EPS Diluted (Quarterly) : -0.5453 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| RadNet, Inc. | -0.0078 |
| Zymeworks, Inc. | -0.547 |
| Xeris Biopharma Holdings, Inc. | 0.0615 |
| Caribou Biosciences, Inc. | -0.2802 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -26.36M |
| Revenue (Quarterly) | 37.84M |
| Total Expenses (Quarterly) | 64.20M |
| Enterprise Value | 913.28M |
| Gross Profit Margin (Quarterly) | 91.31% |
| Profit Margin (Quarterly) | -69.68% |
| Earnings Yield | -17.27% |
| Normalized Earnings Yield | -17.27 |